ImpediMed Limited (IPD.AX)
AUD 0.05
(0.0%)
AUD 0.05
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -19.79 Million AUD | 3.56% |
| 2023 | -20.52 Million AUD | -3.26% |
| 2022 | -19.87 Million AUD | 4.02% |
| 2021 | -20.7 Million AUD | 3.14% |
| 2020 | -21.37 Million AUD | 10.91% |
| 2019 | -23.99 Million AUD | 11.93% |
| 2018 | -27.24 Million AUD | 1.17% |
| 2017 | -27.57 Million AUD | -6.12% |
| 2016 | -25.98 Million AUD | -75.58% |
| 2015 | -14.79 Million AUD | -86.48% |
| 2014 | -7.93 Million AUD | 6.25% |
| 2013 | -8.46 Million AUD | 31.42% |
| 2012 | -12.34 Million AUD | 16.73% |
| 2011 | -14.82 Million AUD | -29.99% |
| 2010 | -11.4 Million AUD | 18.72% |
| 2009 | -14.02 Million AUD | -43.81% |
| 2008 | -9.75 Million AUD | 0.0% |
| 2007 | - AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -9.71 Million AUD | 0.0% |
| 2024 FY | -19.79 Million AUD | 3.56% |
| 2024 Q4 | -10.07 Million AUD | 0.0% |
| 2023 Q2 | -10.81 Million AUD | 0.0% |
| 2023 FY | -20.52 Million AUD | -3.26% |
| 2023 Q4 | -9.7 Million AUD | 0.0% |
| 2022 Q4 | -10.95 Million AUD | 0.0% |
| 2022 FY | -19.87 Million AUD | 4.02% |
| 2022 Q2 | -8.92 Million AUD | 0.0% |
| 2021 Q4 | -10.26 Million AUD | 0.0% |
| 2021 Q2 | -10.43 Million AUD | 0.0% |
| 2021 FY | -20.7 Million AUD | 3.14% |
| 2020 Q2 | -12.94 Million AUD | 0.0% |
| 2020 Q4 | -8.43 Million AUD | 0.0% |
| 2020 FY | -21.37 Million AUD | 10.91% |
| 2019 Q4 | -11.85 Million AUD | 0.0% |
| 2019 Q2 | -12.14 Million AUD | 0.0% |
| 2019 FY | -23.99 Million AUD | 11.93% |
| 2018 Q2 | -14.43 Million AUD | 0.0% |
| 2018 FY | -27.24 Million AUD | 1.17% |
| 2018 Q4 | -12.81 Million AUD | 0.0% |
| 2017 FY | -27.57 Million AUD | -6.12% |
| 2017 Q2 | -13.79 Million AUD | 0.0% |
| 2017 Q4 | -13.77 Million AUD | 0.0% |
| 2016 Q4 | -14.76 Million AUD | 0.0% |
| 2016 FY | -25.98 Million AUD | -75.58% |
| 2016 Q2 | -11.21 Million AUD | 0.0% |
| 2015 FY | -14.79 Million AUD | -86.48% |
| 2015 Q2 | -6.12 Million AUD | 0.0% |
| 2015 Q4 | -8.67 Million AUD | 0.0% |
| 2014 Q4 | -4.34 Million AUD | 0.0% |
| 2014 FY | -7.93 Million AUD | 6.25% |
| 2014 Q2 | -3.58 Million AUD | 0.0% |
| 2013 Q2 | -5.16 Million AUD | 0.0% |
| 2013 Q4 | -3.29 Million AUD | 0.0% |
| 2013 FY | -8.46 Million AUD | 31.42% |
| 2012 Q3 | -3.08 Million AUD | 0.0% |
| 2012 FY | -12.34 Million AUD | 16.73% |
| 2012 Q2 | -3.08 Million AUD | 16.73% |
| 2012 Q1 | -3.7 Million AUD | 0.0% |
| 2012 Q4 | - AUD | 100.0% |
| 2011 Q1 | -2.85 Million AUD | 0.0% |
| 2011 Q2 | -3.7 Million AUD | -29.99% |
| 2011 Q4 | - AUD | 100.0% |
| 2011 FY | -14.82 Million AUD | -29.99% |
| 2011 Q3 | -3.7 Million AUD | 0.0% |
| 2010 Q4 | - AUD | 100.0% |
| 2010 Q3 | -2.85 Million AUD | 0.0% |
| 2010 FY | -11.4 Million AUD | 18.72% |
| 2010 Q2 | -2.85 Million AUD | 18.72% |
| 2010 Q1 | -3.5 Million AUD | 0.0% |
| 2009 Q3 | -3.5 Million AUD | 0.0% |
| 2009 Q4 | - AUD | 100.0% |
| 2009 Q2 | -3.5 Million AUD | -43.81% |
| 2009 Q1 | -2.43 Million AUD | 0.0% |
| 2009 FY | -14.02 Million AUD | -43.81% |
| 2008 Q4 | - AUD | 100.0% |
| 2008 Q2 | -2.43 Million AUD | 0.0% |
| 2008 Q1 | - AUD | 0.0% |
| 2008 FY | -9.75 Million AUD | 0.0% |
| 2008 Q3 | -2.43 Million AUD | 0.0% |
| 2007 Q3 | - AUD | 0.0% |
| 2007 Q4 | - AUD | 0.0% |
| 2007 FY | - AUD | 0.0% |
| 2007 Q2 | - AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| 4DMedical Limited | -35.97 Million AUD | 44.995% |
| Adherium Limited | -10.22 Million AUD | -93.561% |
| Aroa Biosurgery Limited | -9.74 Million AUD | -103.01% |
| Atomo Diagnostics Limited | -6.84 Million AUD | -188.998% |
| Anteris Technologies Ltd | -67.33 Million AUD | 70.609% |
| Control Bionics Limited | -5.91 Million AUD | -234.642% |
| CardieX Limited | -6.76 Million AUD | -192.519% |
| Compumedics Limited | -338 Thousand AUD | -5755.03% |
| Cochlear Limited | 356.8 Million AUD | 105.547% |
| CleanSpace Holdings Limited | -3.12 Million AUD | -532.846% |
| Cyclopharm Limited | -4.7 Million AUD | -320.992% |
| EMVision Medical Devices Ltd | -2.72 Million AUD | -625.012% |
| Nova Eye Medical Limited | -8.79 Million AUD | -125.142% |
| HeraMED Limited | -6.78 Million AUD | -191.73% |
| Imricor Medical Systems, Inc. | -22.62 Million AUD | 12.534% |
| InhaleRx Limited | -1.44 Million AUD | -1271.191% |
| LBT Innovations Limited | -3.74 Million AUD | -429.144% |
| Micro-X Limited | -9.76 Million AUD | -102.663% |
| Neurotech International Limited | -5.06 Million AUD | -290.393% |
| OncoSil Medical Limited | -11.91 Million AUD | -66.112% |
| PolyNovo Limited | 5.26 Million AUD | 476.164% |
| Respiri Limited | -7.12 Million AUD | -177.589% |
| SomnoMed Limited | -12.24 Million AUD | -61.66% |
| Universal Biosensors, Inc. | -6.74 Million AUD | -193.552% |
| Uscom Limited | -2.07 Million AUD | -853.85% |
| Visioneering Technologies, Inc. | -5.06 Million AUD | -290.851% |